[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349488-105":59,"doc-detail-349488-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","economic-evaluation-of-articial-intelligence-for-cancer-detection-in-the-uk-breast-screening-programme","Economic evaluation of artiﬁcial intelligence for cancer detection in the UK breast screening programme","","Economic evaluation of AI in UK breast cancer screening compares strategy costs and health effects across NHS screening pathways. Using a de novo discrete-event simulation model informed by a large prospective trial, the study estimates cost-effectiveness under AI-only, human substitution, and combined reading approaches. Results show small QALY gains with reduced lifetime costs and high probability of cost-effectiveness at the £20,000/QALY threshold. All AI pathways reduce cancer deaths, shift detection toward earlier TNM stages, and increase screening-detected cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/economic-evaluation-of-articial-intelligence-for-cancer-detection-in-the-uk-breast-screening-programme/349488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/economic-evaluation-of-articial-intelligence-for-cancer-detection-in-the-uk-breast-screening-programme/349488.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in the UK breast screening programme?","Question",{"text":112,"@type":113},"The study addresses workforce pressures from breast radiologist shortages and the need to maintain timely double reading while preserving diagnostic accuracy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the cost-effectiveness of AI evaluated?",{"text":117,"@type":113},"A de novo discrete-event simulation model was built to estimate cost-effectiveness when integrating AI into the NHS screening pathway, using evidence from a large prospective trial.",{"name":119,"@type":110,"acceptedAnswer":120},"Which screening strategy was most cost-effective, and what were the main outcomes?",{"text":121,"@type":113},"Full replacement of both human readers was described as most cost-effective. AI-based pathways reduced cancer deaths, increased detection by screening, and shifted cancers toward earlier TNM stages.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349488,1790176357,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nEpidemiology  \nEconomic evaluation of artiﬁcial intelligence for cancer detection in the UK breast screening programme  \nHarry Hill 1,3 ✉ and Cristina Roadevin 2,3  \n© Crown 2026  \n\n|  | BACKGROUND: Artiﬁcial intelligence (AI) offers a potential solution to radiologist shortages in breast cancer screening while maintaining diagnostic accuracy. Retrospective studies suggest AI performs comparably to human readers in detecting cancers, but no economic evaluations have yet used prospective trial data.\u003Cbr>METHODS: We developed a de novo discrete-event simulation model to estimate the cost-effectiveness of integrating AI into the NHS screening pathway using evidence from a large prospective trial.\u003Cbr>RESULTS: The AI-only strategy generated a small incremental QALY gain of 0.00009 and reduced lifetime costs by £159.55 per woman invited, and had a 100% probability of being most cost-effective at the £20,000/QALY threshold. Replacing one human reader with AI also increased QALYs, by 0.00019, and reduced costs by £31.07 . Triple reading (two humans plus AI) produced the largest QALY gain (0.00023) but increased costs by £72.79 . All AI-based pathways reduced cancer deaths, shifted cancers from advanced (TNM stage 4) to earlier stages at detection, and increased the proportion of cancers detected by screening. CONCLUSION: Using AI in place of human readers is likely to be cost-effective, marginally improving health outcomes while |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| reducing overall costs, with full replacement of both human readers being the most cost-effective screening strategy. |  |  |\n|  | British Journal of Cancer (2026) 135:453–460; [https://doi.org/10.1038/s41416-026-03465-3](https://doi.org/10.1038/s41416-026-03465-3) |  |\n|  |  |  |\n\nINTRODUCTION  \nBreast cancer screening offers important beneﬁts but also carries recognised harms, and its effectiveness has long been the subject of debate [1] . Contemporary evidence indicates that early detection contributes to a reduction in breast cancer mortality [2, 3], although both the magnitude of this beneﬁt and the extent of overdiagnosis remain areas of discussion [1, 4] . An international meta-analysis of cohort studies [3] demonstrated that participation in organised mammography screening programmes reduces incidence-based breast cancer mortality by approximately 20-30% . Evidence also suggests that these mortality gains are delivered atan economically acceptable cost. A systematic review [5] of 32 economic evaluations of breast cancer screening and seven evaluations of primary prevention found that all studies predicted gains in life expectancy at costs considered acceptable within their respective healthcare systems, based on evidence from European screening programmes.  \nThe NHS Breast Screening Programme invites women aged 50 up to their 71st birthday for routine mammography every three years [6] . Each mammogram is double-read, meaning that two radiologists independently interpret the images. Since its launch in 1988, the NHS Breast Screening Programme has been associated with improvements in breast cancer outcomes. Contemporary population-based evidence in England shows  \nlower mortality among women who attend screening, with a national case-control analysis reporting a 38% mortality reduction [7] and another study ﬁnding a 21% reduction after adjustment for the healthier-volunteer effect [8] . Concerns about overdiagnosis and the balance of beneﬁts and harms also continue to inform debates on how screening programmes should be organised [1, 9] .  \nThese debates are set against a backdrop of operational pressures. The NHS faces a shortage of breast radiologists. Recent workforce data from the Royal College of Radiologists report the UK has a 29% shortfall of consultant clinical radiologists, wit","cbCais9yFLB4YJ6Y","https://ap.wps.com/l/cbCais9yFLB4YJ6Y","pdf",484804,"English","# Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## NHS breast screening programme and workforce pressures\n## Role of AI in mammography reading\n# Model structure and screening pathways","[{\"question\":\"What problem does the study address in the UK breast screening programme?\",\"answer\":\"The study addresses workforce pressures from breast radiologist shortages and the need to maintain timely double reading while preserving diagnostic accuracy.\"},{\"question\":\"How was the cost-effectiveness of AI evaluated?\",\"answer\":\"A de novo discrete-event simulation model was built to estimate cost-effectiveness when integrating AI into the NHS screening pathway, using evidence from a large prospective trial.\"},{\"question\":\"Which screening strategy was most cost-effective, and what were the main outcomes?\",\"answer\":\"Full replacement of both human readers was described as most cost-effective. AI-based pathways reduced cancer deaths, increased detection by screening, and shifted cancers toward earlier TNM stages.\"}]","Economic evaluation of artiﬁcial intelligence for cancer detection in the UK breast screening programme | PDF",1790083516,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc23cd62145f5d8b7796bc4049c862b5.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6a4a2d9798cc673a8af74363ea73718.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db54f720690641c3915057bcd620fc5e.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0108054d8aa7e2fb703667708d06607d.webp",980,1301]